72.71
price down icon1.50%   -1.11
after-market Handel nachbörslich: 72.71
loading
Schlusskurs vom Vortag:
$73.82
Offen:
$73.44
24-Stunden-Volumen:
504.26K
Relative Volume:
0.70
Marktkapitalisierung:
$3.65B
Einnahmen:
$379.25M
Nettoeinkommen (Verlust:
$-77.34M
KGV:
-45.10
EPS:
-1.6122
Netto-Cashflow:
$-27.87M
1W Leistung:
-0.33%
1M Leistung:
-2.90%
6M Leistung:
+85.86%
1J Leistung:
+88.96%
1-Tages-Spanne:
Value
$71.43
$74.16
1-Wochen-Bereich:
Value
$71.43
$78.54
52-Wochen-Spanne:
Value
$36.88
$78.54

Mirum Pharmaceuticals Inc Stock (MIRM) Company Profile

Name
Firmenname
Mirum Pharmaceuticals Inc
Name
Telefon
650-667-4085
Name
Adresse
989 EAST HILLSDALE BOULEVARD, SUITE 300, FOSTER CITY
Name
Mitarbeiter
349
Name
Twitter
@mirumpharma
Name
Nächster Verdiensttermin
2024-11-04
Name
Neueste SEC-Einreichungen
Name
MIRM's Discussions on Twitter

Vergleichen Sie MIRM mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
MIRM
Mirum Pharmaceuticals Inc
72.71 3.71B 379.25M -77.34M -27.87M -1.6122
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
407.79 106.37B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
460.46 59.90B 2.46B -319.09M -52.09M -2.4669
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
564.63 60.40B 14.21B 4.46B 3.56B 39.69
Biotechnology icon
ARGX
Argen X Se Adr
796.92 49.56B 3.06B 1.28B 447.35M 19.67
Biotechnology icon
ONC
Beone Medicines Ltd Adr
320.10 36.88B 4.56B -176.77M 225.30M -1.7177

Mirum Pharmaceuticals Inc Stock (MIRM) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-09-24 Eingeleitet TD Cowen Buy
2025-08-11 Fortgesetzt Stifel Buy
2025-05-19 Fortgesetzt H.C. Wainwright Buy
2024-04-17 Eingeleitet Stifel Buy
2023-12-18 Bestätigt H.C. Wainwright Buy
2023-11-20 Fortgesetzt JP Morgan Overweight
2023-11-13 Eingeleitet Morgan Stanley Overweight
2023-10-24 Eingeleitet Cantor Fitzgerald Overweight
2023-10-17 Fortgesetzt Evercore ISI Outperform
2023-09-20 Eingeleitet JMP Securities Mkt Outperform
2022-09-01 Eingeleitet Citigroup Buy
2021-09-20 Eingeleitet JP Morgan Overweight
2020-08-07 Hochstufung Raymond James Outperform → Strong Buy
2020-08-03 Eingeleitet H.C. Wainwright Buy
2020-07-31 Eingeleitet Piper Sandler Overweight
2020-06-25 Eingeleitet Robert W. Baird Outperform
2019-08-12 Eingeleitet Citigroup Buy
2019-08-12 Eingeleitet Evercore ISI Outperform
2019-08-12 Eingeleitet Guggenheim Buy
2019-08-12 Eingeleitet ROTH Capital Buy
2019-08-12 Eingeleitet Raymond James Outperform
Alle ansehen

Mirum Pharmaceuticals Inc Aktie (MIRM) Neueste Nachrichten

pulisher
Oct 10, 2025

Technical signs of recovery in Mirum Pharmaceuticals Inc.Oil Prices & Short-Term High Return Ideas - newser.com

Oct 10, 2025
pulisher
Oct 10, 2025

Is Mirum Pharmaceuticals Inc. reversing from oversold territory2025 Technical Patterns & Low Drawdown Investment Ideas - newser.com

Oct 10, 2025
pulisher
Oct 10, 2025

Mirum Pharmaceuticals' (MIRM) "Sell (D-)" Rating Reiterated at Weiss Ratings - MarketBeat

Oct 10, 2025
pulisher
Oct 10, 2025

How to use a screener to detect Mirum Pharmaceuticals Inc. breakoutsJuly 2025 Volume & High Accuracy Swing Entry Alerts - newser.com

Oct 10, 2025
pulisher
Oct 10, 2025

Can Mirum Pharmaceuticals Inc. (08D) stock survive global slowdownInflation Watch & Low Drawdown Investment Ideas - newser.com

Oct 10, 2025
pulisher
Oct 10, 2025

Is Mirum Pharmaceuticals Inc 08D a good long term investmentRisk Management Strategies & Affordable Portfolio Trading - earlytimes.in

Oct 10, 2025
pulisher
Oct 10, 2025

Will Mirum Pharmaceuticals Inc. rebound enough to break evenDollar Strength & Daily Profit Focused Screening - newser.com

Oct 10, 2025
pulisher
Oct 09, 2025

Branded Website for Consumers 2025 - Medical Marketing and Media

Oct 09, 2025
pulisher
Oct 09, 2025

Mirum Pharmaceuticals stock hits all-time high at 78.23 USD - Investing.com India

Oct 09, 2025
pulisher
Oct 09, 2025

What data driven models say about Mirum Pharmaceuticals Inc.’s futureJuly 2025 Opening Moves & Real-Time Market Sentiment Alerts - newser.com

Oct 09, 2025
pulisher
Oct 09, 2025

Will Mirum Pharmaceuticals Inc. stock recover faster than peersIndex Update & Risk Controlled Daily Trade Plans - newser.com

Oct 09, 2025
pulisher
Oct 06, 2025

Custom watchlist performance reports with Mirum Pharmaceuticals Inc.2025 Trading Recap & Stock Portfolio Risk Control - newser.com

Oct 06, 2025
pulisher
Oct 06, 2025

Is Mirum Pharmaceuticals Inc. stock near bottom after declineDollar Strength & Free Real-Time Market Sentiment Alerts - newser.com

Oct 06, 2025
pulisher
Oct 06, 2025

How to integrate Mirum Pharmaceuticals Inc. into portfolio analysis toolsEarnings Growth Summary & Fast Exit/Entry Strategy Plans - newser.com

Oct 06, 2025
pulisher
Oct 06, 2025

Why Mirum Pharmaceuticals Inc. (08D) stock is listed among top recommendationsQuarterly Market Summary & Technical Pattern Recognition Alerts - newser.com

Oct 06, 2025
pulisher
Oct 05, 2025

How sentiment analysis helps forecast Mirum Pharmaceuticals Inc.Sell Signal & AI Enhanced Trading Signals - newser.com

Oct 05, 2025
pulisher
Oct 05, 2025

Identifying reversal signals in Mirum Pharmaceuticals Inc.July 2025 Technicals & Daily Entry Point Alerts - newser.com

Oct 05, 2025
pulisher
Oct 05, 2025

Mirum Pharmaceuticals, Inc. $MIRM Shares Sold by Wealth Enhancement Advisory Services LLC - MarketBeat

Oct 05, 2025
pulisher
Oct 03, 2025

Is Mirum Pharmaceuticals Inc. forming a bottoming baseQuarterly Performance Summary & Risk Controlled Stock Pick Alerts - newser.com

Oct 03, 2025
pulisher
Oct 03, 2025

Price action breakdown for Mirum Pharmaceuticals Inc.Market Activity Report & Stepwise Entry and Exit Trade Signals - newser.com

Oct 03, 2025
pulisher
Sep 30, 2025

Is Mirum Pharmaceuticals Inc a good long term investmentBearish Engulfing Patterns & Free Wealth Planning Blueprints - earlytimes.in

Sep 30, 2025
pulisher
Sep 29, 2025

Mirum Pharmaceuticals stock soars to all-time high of $49.59 - MSN

Sep 29, 2025
pulisher
Sep 29, 2025

Mirum draws new Buy at TD Cowen on growth prospects - MSN

Sep 29, 2025

Finanzdaten der Mirum Pharmaceuticals Inc-Aktie (MIRM)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading

Mirum Pharmaceuticals Inc-Aktie (MIRM) Insiderhandel

Insiderhandel Beziehung Datum Transaktion Kosten #Aktien Wert ($) #Aktien Gesamt
Brege Laura
Director
Sep 11 '25
Sale
74.40
17,000
1,264,868
15,703
BJERKHOLT ERIC
CHIEF FINANCIAL OFFICER
Sep 12 '25
Sale
76.01
9,578
728,024
39,945
$21.35
price down icon 5.74%
$83.80
price down icon 1.12%
$31.81
price down icon 0.13%
$102.06
price down icon 2.32%
$162.33
price down icon 1.26%
biotechnology ONC
$320.10
price down icon 4.68%
Kapitalisierung:     |  Volumen (24h):